Metsera's obesity drug shows promising weight loss in mid-stage trials

Core Viewpoint - Metsera's experimental obesity drug demonstrated significant weight loss and favorable tolerability in mid-stage studies [1] Group 1 - The drug showed promising results in terms of weight loss during the mid-stage trials [1] - Tolerability of the drug was reported to be favorable, indicating a potentially positive safety profile [1]